|
 |
European Pharmaceutical Contractor
|
| The task of organising and implementing training strategies in the pursuit of a talented workforce can be fiendishly difficult, and the lack of obvious answers continues to cause consternation. Steve Pinder of MDS Pharma Services offers up some direct experiences
When I first joined the pharmaceutical industry 15 years ago, I thought training was a simple issue. I assumed that I would get a few hours of instruction from my manager (perhaps supplemented by very occasional external courses) and that I would then be expected to work out how to apply that training to my day-to-day work for myself. That was it. That’s what training meant to me. I had no idea that trainers could be hired to deliver training internally. I thought ‘conferences’ were lengthy events where you presented your PhD thesis on a poster to academics who pretended to be interested out of kindness and a sense of duty. The Internet and e-learning didn’t exist. Mentally, ‘coaching’ and ‘sport’ were inextricably linked. How naïve.
Today, in mid-career, I am fortunate to have had direct experience of numerous perspectives on training. During my pharmaceutical career, I progressed from novice through developing professional to manager of multiple functions. In the service sector, I began as a departmental manager, took the opportunity to become a trainer (of internal staff and of feepaying external delegates), went on to become a global business leader in my company and, finally, took on responsibility for the management of my organisation’s commercial training division. At no point in this progression did I think to myself ‘this is great, I’m receiving an awful lot of training here’. Looking back, however, I was certainly very fortunate with what was available to me, and the things that I learned are applied in each and every day’s work that I do. |
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
Azopharma Product Development Group, Inc
HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today the addition of innovative state-of-the-art equipment at its formulation and manufacturing division, ApiCross Drug Delivery Technologies in Hollywood, Florida. The most recent acquisition is the MG Futura Capsule Filler which delivers the latest in capsule filling technology. The company has also added a Bausch & Strobel Aseptic Filling Isolator, equipment that is ground-breaking in the powder filling process. These additions support our previously implemented XcelodoseTM powder micro-dosing system. With these technologies, Azopharma is able to provide its clients with all forms of the capsule filling process. The new equipment is part of Azopharma’s recent manufacturing expansion which includes 17 new manufacturing suites for GMP, cytotoxic and aseptic products...
More info >> |
|
 |
